• Policy
• Are there any countermeasures against Rx of hair loss pills?
• by Lee, Jeong-Hwan Aug 25, 2023 06:06am

• Policy
• Bayer completes pricing negotiations for Jivi Inj in KOR
• by Lee, Tak-Sun Aug 25, 2023 06:06am

• Policy
• Reduction in the scope of platform regulation & re-examinati
• by Lee, Jeong-Hwan Aug 25, 2023 06:06am

• Policy
• Verquvo will be listed for reimb at KRW 2,867 in KOR
• by Kim, Jung-Ju Aug 24, 2023 05:46am

• Policy
• Generics for Januvia are deleted from the reimbursement list
• by Lee, Tak-Sun Aug 24, 2023 05:46am

• Policy
• Conflict rise over the need of the PE exemption system
• by Lee, Jeong-Hwan Aug 24, 2023 05:45am

• Policy
• 157 single and 82 combo Januvia generics reimbursed in KOR
• by Lee, Tak-Sun Aug 23, 2023 05:46am

• Policy
• 'No other country has a PE exemption system'
• by Lee, Jeong-Hwan Aug 23, 2023 05:46am

• Policy
• Envlomet SR is priced at 611 won, the same price as Envlo
• by Lee, Tak-Sun Aug 23, 2023 05:46am

• Policy
• Will Pfizer rise to the top with once-weekly growth hormone?
• by Lee, Tak-Sun Aug 22, 2023 05:31am